Cargando…

Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array

PURPOSE: To determine the immunogenicity of diphtheria toxoid (DT) formulated in two types of vesicles following transcutaneous immunization (TCI) of mice onto microneedle array-treated skin. METHODS: DT-containing cationic liposomes or anionic surfactant-based vesicles were prepared by extrusion an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zhi, Bal, Suzanne M., Romeijn, Stefan, Kersten, Gideon F. A., Jiskoot, Wim, Bouwstra, Joke A.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003783/
https://www.ncbi.nlm.nih.gov/pubmed/20237826
http://dx.doi.org/10.1007/s11095-010-0093-y
_version_ 1782193901219610624
author Ding, Zhi
Bal, Suzanne M.
Romeijn, Stefan
Kersten, Gideon F. A.
Jiskoot, Wim
Bouwstra, Joke A.
author_facet Ding, Zhi
Bal, Suzanne M.
Romeijn, Stefan
Kersten, Gideon F. A.
Jiskoot, Wim
Bouwstra, Joke A.
author_sort Ding, Zhi
collection PubMed
description PURPOSE: To determine the immunogenicity of diphtheria toxoid (DT) formulated in two types of vesicles following transcutaneous immunization (TCI) of mice onto microneedle array-treated skin. METHODS: DT-containing cationic liposomes or anionic surfactant-based vesicles were prepared by extrusion and sonication. The physicochemical properties were characterized in terms of size, ζ-potential, vesicle elasticity and antigen association. TCI was performed by applying formulations onto intact or microneedle array-pretreated mice skin, using cholera toxin as an adjuvant. Subcutaneous and intradermal immunizations were as control. Immune responses were evaluated by IgG and neutralizing antibody titers, and the immune-stimulatory properties were assessed using cultured dendritic cells. RESULTS: Stable DT-containing cationic liposomes (∼150 nm) and anionic vesicles (∼100 nm) were obtained. Incorporation of Span 80 increased liposome elasticity. About 90% and 77% DT was associated with liposomes and vesicles, respectively. TCI of all formulations resulted in substantial antibody titers only if microneedle pretreatment was applied. Co-administration of cholera toxin further augmented the immune responses of TCI. However, vesicle formulations didn’t enhance the immunogenicity on either intact or microneedle-treated skin and showed low stimulatory activity on dendritic cells. CONCLUSIONS: Microneedle pretreatment and cholera toxin, but not antigen association to vesicles, enhances the immunogenicity of topically applied DT.
format Text
id pubmed-3003783
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-30037832011-01-19 Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array Ding, Zhi Bal, Suzanne M. Romeijn, Stefan Kersten, Gideon F. A. Jiskoot, Wim Bouwstra, Joke A. Pharm Res Research Paper PURPOSE: To determine the immunogenicity of diphtheria toxoid (DT) formulated in two types of vesicles following transcutaneous immunization (TCI) of mice onto microneedle array-treated skin. METHODS: DT-containing cationic liposomes or anionic surfactant-based vesicles were prepared by extrusion and sonication. The physicochemical properties were characterized in terms of size, ζ-potential, vesicle elasticity and antigen association. TCI was performed by applying formulations onto intact or microneedle array-pretreated mice skin, using cholera toxin as an adjuvant. Subcutaneous and intradermal immunizations were as control. Immune responses were evaluated by IgG and neutralizing antibody titers, and the immune-stimulatory properties were assessed using cultured dendritic cells. RESULTS: Stable DT-containing cationic liposomes (∼150 nm) and anionic vesicles (∼100 nm) were obtained. Incorporation of Span 80 increased liposome elasticity. About 90% and 77% DT was associated with liposomes and vesicles, respectively. TCI of all formulations resulted in substantial antibody titers only if microneedle pretreatment was applied. Co-administration of cholera toxin further augmented the immune responses of TCI. However, vesicle formulations didn’t enhance the immunogenicity on either intact or microneedle-treated skin and showed low stimulatory activity on dendritic cells. CONCLUSIONS: Microneedle pretreatment and cholera toxin, but not antigen association to vesicles, enhances the immunogenicity of topically applied DT. Springer US 2010-03-17 2011 /pmc/articles/PMC3003783/ /pubmed/20237826 http://dx.doi.org/10.1007/s11095-010-0093-y Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Research Paper
Ding, Zhi
Bal, Suzanne M.
Romeijn, Stefan
Kersten, Gideon F. A.
Jiskoot, Wim
Bouwstra, Joke A.
Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array
title Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array
title_full Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array
title_fullStr Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array
title_full_unstemmed Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array
title_short Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array
title_sort transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003783/
https://www.ncbi.nlm.nih.gov/pubmed/20237826
http://dx.doi.org/10.1007/s11095-010-0093-y
work_keys_str_mv AT dingzhi transcutaneousimmunizationstudiesinmiceusingdiphtheriatoxoidloadedvesicleformulationsandamicroneedlearray
AT balsuzannem transcutaneousimmunizationstudiesinmiceusingdiphtheriatoxoidloadedvesicleformulationsandamicroneedlearray
AT romeijnstefan transcutaneousimmunizationstudiesinmiceusingdiphtheriatoxoidloadedvesicleformulationsandamicroneedlearray
AT kerstengideonfa transcutaneousimmunizationstudiesinmiceusingdiphtheriatoxoidloadedvesicleformulationsandamicroneedlearray
AT jiskootwim transcutaneousimmunizationstudiesinmiceusingdiphtheriatoxoidloadedvesicleformulationsandamicroneedlearray
AT bouwstrajokea transcutaneousimmunizationstudiesinmiceusingdiphtheriatoxoidloadedvesicleformulationsandamicroneedlearray